TAKE Solutions Ltd. announces the launch of Navitas – a pure-play Life Sciences solutions company, by bringing together the proven expert teams of TAKE Life Sciences and WCI Consulting.
Navitas has been created within TAKE Solutions to stand as a differentiated entity offering niche solutions for the Pharma/Biotech industry. The restructuring of the business is an integral part of TAKE’s go-to-market strategy to meet multiple objectives such as catering to the regulatory demands of clients and creating a more efficient organization which can focus on innovation.
The capabilities of the new Life Sciences arm of TAKE Solutions covers Industry leading networks, strategic & change management consulting, technology and services which are focused on the Clinical, Regulatory, Safety and Compliance domains. The new pure-play Life Sciences solutions company will cater to clients ranging in size and complexity.
Srinivasan H R, Vice-Chairman and Managing Director, TAKE Solutions & Chairman, Navitas said, “There is a demand in the global Pharma/Life Sciences market for regulatory compliance and customized solutions to meet business needs. The total addressable market of the Life Science industry is valued at USD 15.9 billion. Our move to create a new brand is to meet the demand of this market in time to emerge as a competent and differentiated player. We have seen immense positive growth in this segment with our solutions in this space resonating well with customers. Our plan is to capitalize on it, gear up to meet the changing business environments and compete with industry leaders”.
